Earnings Feed
Start Free
Home/Filings/4/0001209191-10-047743
4//SEC Filing

Crompton R Michael 4

Accession 0001209191-10-047743

CIK 0001028318other
View on SEC.govCompany Profile

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 6:06 PM ET

Size

21.5 KB

Accession

0001209191-10-047743

Insider Transaction Report

Form 4
Period: 2010-09-27
MICRUS ENDOVASCULAR CORPMEND
Crompton R Michael
VP Regulatory,Clinical&Quality
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$14.21/sh−10,625$150,981→ 0 total
    Exercise: $9.19Exp: 2019-05-26→ Common Stock (10,625 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$5.89/sh−4,167$24,544→ 0 total
    Exercise: $17.51Exp: 2017-11-12→ Common Stock (4,167 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$11.98/sh−15,549$186,277→ 0 total
    Exercise: $11.42Exp: 2018-05-14→ Common Stock (15,549 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$10.77/sh−28,332$305,136→ 0 total
    Exercise: $12.63Exp: 2016-10-02→ Common Stock (28,332 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$11.98/sh−4,451$53,323→ 0 total
    Exercise: $11.42Exp: 2018-05-14→ Common Stock (4,451 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$14.21/sh−19,375$275,319→ 0 total
    Exercise: $9.19Exp: 2019-05-26→ Common Stock (19,375 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$5.89/sh−15,833$93,256→ 0 total
    Exercise: $17.51Exp: 2017-11-12→ Common Stock (15,833 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$10.77/sh−31,668$341,064→ 0 total
    Exercise: $12.63Exp: 2016-10-02→ Common Stock (31,668 underlying)
Footnotes (1)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., this stock option was converted into the right to receive an amount in cash per share subject to the stock option equal to the excess of the per share merger consideration of $23.40 over the per share exercise price of such stock option, without interest.

Documents

1 file

Issuer

MICRUS ENDOVASCULAR CORP

CIK 0001028318

→
Entity typeother

Related Parties

1
  • filerCIK 0001376975

Filing Metadata

Form type
4
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 6:06 PM ET
Size
21.5 KB
View on SEC.gov